Perspectives of development of cadaveric hepatic transplantation

Abstract

no abstract

Author Biographies

M. I. Tutchenko, Bogomolets National Medical University, Kyiv

Tutchenko Nikolay Ivanovich – MD, PhD., Professor,

head of the department of surgery - Bohomolets National Medical University

Ukraine, Kyiv, st. Bratislavska 3,

044-518 - 62 - 11

E-mail : tutchenko@ukr.net,

ORSID : http://orcid.org/0000-0002-5050-6494

B. I. Sloneckyi, Shupyk National medical Academy of Postgraduate Education, Kyiv

Sloneckyi Boris Ivanovich – MD, PhD, Professor

Department of Emergency Medicine

Shupyk National Medical Academy of Postgraduate Education

Ukraine, Kyiv, st. Dorogozhtska 9,

(0504488776, 044-518 - 62 - 11),

E-mail slobis@ukr.net,

ORSID : http://orcid.org/0000-0002-2049-5894

D. V. Rudyk, Bogomolets National Medical University, Kyiv

Rudyk Diana Vitaliivna – MD, PhD, Assistant

department of surgery

 of the dental faculty of the O.O.

Bohomolets National Medical University,

Ukraine, Kyiv, st. Bratislavska 3,

044-518 - 62 – 11

E-mail : rudyk@ukr.net,

ORSID : http://orcid.org/0000-0001-9736-3614

References

1. Meirelles, Junior RF. Liver transplantation: history, outcomes and perspectives Einstein(Sao Paulo).2015 Jan-Mar; 13(1):149-521. doi: 10.1590/S167-45082015 RW3164
2. Starzl TE, Iwatsuki S, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ, et al. Evolution of liver transplantation. Hepatology. 1982;2:614-36, PMCID: PMC2972731. PMID: 6749635
3. Moini M, Schilsky ML, Tichy EM. Review on immunosuppression in liver transplantation. World J Hepatol. 2015 Jun 8;7(10):1355-68. doi: 10.4254/wjh.v7.i10.135515.
4. Wilson GC, Quillin RC 3rd, Wima K, Sutton JM, Hoehn RS, Hanseman DJ, et al. Is liver transplantation safe and effective in elderly (>70 years) recipients? A case-controlled analysis. HPB (Oxford). 2014;16:1088-94. doi: 10.1111/hpb.12312.
5. Aduen JF, Sujay B, Dickson RC, Heckman MG, Hewitt WR, Stapelfeldt WH, et al. Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc. 2009;84:973-8.
6.Grat M, Kornasiewicz O, Grat K, Antczak A, Ligocka J, Holowko W, et al. Short and long-term outcomes after primary liver transplantation in elderly patients. Pol Prz Chir. 2013;85:581-8. doi: 10.2478/pjs-2013-0087.
7. Van Hoek B1, de Rooij BJ, Verspaget HW. Risk factors for infection after liver transplantation. Best Pract Res Clin Gastroenterol. 2012 Feb;26(1):61-72. doi: 10.1016/j.bpg.2012.01.004.
8. Maggi U1, Nita G, Gatti S, Antonelli B, Paolo R, Como G, et al. Hyperbilirubinemia after liver transplantation: the role of coupled plasma filtration adsorption. Transplant Proc. 2013 Sep;45(7):2715-7. doi: 10.1016/j.transproceed.2013.07.019.
9. She WH, Chok KS, Lo RC, Chan SC, Lo CM. Rare cause of jaundice in a post liver transplant patient. Transpl Infect Dis. 2015 Aug;17(4):579-82. doi: 10.1111/tid.12414.;45(7):2715-7.
10. Nemes B, Gámán G, Doros A. Biliary complications after liver transplantation. Expert Rev Gastroenterol Hepatol. 2015;9(4):447-66. doi: 10.1586/17474124.2015.967761.
11. Cui Cui, Fang Yu, Suqing Yin, Yuting Yang, Yingfu Jiao, Chiwai Cheung, et al. Remifentanil Preconditioning Attenuates Hepatic Ischemia-Reperfusion Injury in Rats via Neuronal. Mediators Inflamm. 2018; Published online 2018 May 10. doi: 10.1155/2018/3260256.
12. Pickard JMJ, Davidson SM, Hausenloy DJ, Yellon D. M. Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning. Basic Res Cardiol. 2016;111(4):p. 50. doi: 10.1007/s00395-016-0568-z.
13. Chandra Kant Pandey, Soumya S Nath,1 Vijay K Pandey, Sunaina T Karna, Manish Tandon. Perioperative ischaemia-induced liver injury and protection strategies: An expanding horizon for anaesthesiologists. Indian J Anaesth. 2013 May-Jun; 57(3):223-9. doi: 10.4103/0019-5049.115576.
14. Leithead JA, Ferguson JW. Chronic kidney disease after liver transplantation. J Hepatol. 2015 Jan;62 (1):243-4. doi:10.1016/j.jhep.2014.08.054.
15. Elsa Solà, Pere Ginès'. Chronic kidney disease: A major concern in liver transplantation in the XXI century. J Hepatol. 2014Aug; 61(2):196-7. doi.org/10.1016/j.jhep.2014.05.011.
16. Liu PY, Cheng SB, Lin CC, Lin CH, Chang SN, Cheng CY, et al. Cytomegalovirus disease after liver transplantation: a nationwide population-based study. Transplant Proc. 2014;46:832-4. doi;10.1016/j.transproceed.2013.12.009.
17. Chen HP, Tsai YF, Lin JR, Liu FC, Yu HP. Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study. PLoS One. 2016 Mar 28;11(3):e0152324. doi: 10.1371/journal.pone.0152324.
18. Kaneko J, Sugawara Y, Tamura S, Aoki T, Sakamoto, Hasegawa K, et al. De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: comparison with a Japanese population-based study. Transplantation. 2013;95:1142-7. doi: 10.1097/TP.0b013e318288ca83
19. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608. doi: 10.1016/j.jhep.
20. Silvestri C, Voller F, Cipriani F. Epidemiology of Liver Cirrhosis. J Clin Exp Hepatol. 2015 Sep;5(3):272. doi: 10.1016/j.jceh.2015.06.002
21. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-35. doi:10.1002/hep.28906.
22. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310-24. doi: 10.1016/j.jhep.
23.Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-35. doi: 10.1002/hep.27210.
24. Dionigi E, Garcovich M, Borzio M, Leandro G, Majumdar A, Tsami A, et al. Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity. Am J Gastroenterol. 2017;112:588-96. doi: 10.1038/ajg.
25. D'Amico G, Pasta L, Morabito A, D'Amico M, Caltagirone M, Malizia G, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39:1180-93. doi: 10.1111/apt.12721.
26. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, et al. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. Gastroenterology. 2017;152:1090-9. doi:10.1053/j.gastro.
27. Fernandez Carrillo C, Lens S, Llop E, Pascasio JM, Crespo J, Arenas J, et al. Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry. Hepatology. 2017;65:1810-22. doi:10.1002/hep.29097.
28 Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018 Jan;67(1):123-33. doi: 10.1002/hep.29466.
29. Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, et al. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl. 2014;20:1193-201. doi: 10.1002/lt.23929.
30. Everson GT, Terrault NA, Lok AS, Rodrigo DR, Brown RS Jr, et al. Viral Hepatitis Free Access. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation, Hepatology. 2012 May;57(Issue 5):1681-2095. doi.org/10.1002/hep.25976.
31. Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412-9. doi.org/10.1053/j.gastro.2013.10.018.
32. Kanwal F, Tansel A, Kramer JR, Feng H, Asch SM, El-Serag HB. Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. Am J Gastroenterol. 2017;112(8):1287-97. doi: 10.1038/ajg.2017.175.
33. Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150:835-53. doi:10.1053/j.gastro.
34. Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141-55. doi: 10.1586/egh.12.83.
35. Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, et al. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites. Gastroenterology. 2017;152:157-63. doi.org/10.1053/J.gastro.2016.09.016.
36. Sarin SK, Kumar A, Angus PW, et al. Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int. 2011;5:607-24. doi: 10.1007/s12072-010-9236-9.
37. Tutchenko MI, Rudyk DV, Iskra NI, Trofimenko SP, Shchur IV. Modern view on intensive therapy of gastro-intestinal hemorrhage. Klinichna khirurhiia. 2015;(10):11-4. [In Russian].
38. Kim YD. Management of Acute Variceal Bleeding. Clin Endosc. 2014 Jul; 47(4):308-14. doi: 10.5946/ce.2014.47.4.308.
39. Cooper DK, Hara H, Ezzelarab M, Bottino R, Trucco M, Phelps C, et al. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantations. J Biome Ris. 2013;27(4):249-53.
40. Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH. The MELD system and liver transplant waiting list mortality in diveloping countries. Lessons learnd from Sao Paulo, Brazil. Finstein. 2012;10(3):278-85.
41. Fox AN, Brown RS Jr. Is the patient a candidate for liver transplantation? Clin Liver Dis. 2012;16(2):435-48. doi: 10.1016/J. CLD 2012.03.014.
42. Nykonenko AS, Hrytsenko SN, Sobokar' VA, Salenyuk VV, Voronoy AA. Anestezyya y yntraoperatsyonnaya yntensyvnaya terapyya pry transplantatsyy pecheny. Medytsyna s'ohodni i zavtra. 2011;1-2:258-64. [In Russian].
43. Kotenko OH, Minich AA, Hrynenko OV, Popov OO, Husyev AV, Hryhoryan MS, et al. Funktsiya transplantata pravoyi chastky pechinky vid zhyvoho rodynnoho donora. Klinichna khirurhiia. 2018;85(2):5-8. doi:10.26779/2522-1396.2018.02.05. [In Ukrainia].
Published
2019-01-23
How to Cite
Tutchenko, M. I., Sloneckyi, B. I., & Rudyk, D. V. (2019). Perspectives of development of cadaveric hepatic transplantation. Klinicheskaia Khirurgiia, 85(11), 78-80. https://doi.org/10.26779/2522-1396.2018.11.78